2 completed, 1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow etanercept biosimilar SB4: new trials by email Literature Review of etanercept biosimilar SB4 trials Research Report on etanercept biosimilar SB4
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorders MB04, US License Enbrel, EU Source Enbrel - Healthy Volunteers | Phase 1 | Completed | mAbxience Research S.L. | 141 | 2024-03-07 | 2025-09-30 |
| RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis Infliximab, Adalimumab, Etanercept - RheumatoId Arthritis | Terminated | TcLand Expression S.A. | 250 | 2016-12-01 | 2019-12-24 | |
| Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis Etanercept - Rheumatoid Arthritis, Ankylosing Spondylitis | Completed | AryoGen Pharmed Co. | 583 | 2014-04-04 | 2020-10-19 |
Arthritis, Rheumatoid (2) · Arthritis, Psoriatic (1) · Spondylitis, Ankylosing (1)
AryoGen Pharmed Co. (1) · TcLand Expression S.A. (1) · mAbxience Research S.L. (1)
Netherlands (2) · Czechia (1) · France (1) · Iran (1) · Israel (1) · Turkey (Türkiye) (1)